Fortress Biotech, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Bay Harbor Islands, FL
FBIOP chart
What traders are saying about $FBIOP
Latest postsFortress Biotech, Inc. news
- Fortress Biotech repaid USD 15.00 million debt. Fortress Biotech stock is valued at USD 64.7 million
ad-hoc-news.de ·
- Journey Medical Corporation to Participate in September 2026 Investor Conferences
Yahoo Finance ·
- Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Fortress Biotech, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- Fortress Biotech (FBIO) Q2 2026 Earnings Call Transcript
fool.com ·
- Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Yahoo Finance ·
- Fortress Biotech Q2 Earnings Call Highlights
marketbeat.com ·
- Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Yahoo Finance ·
- Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
Yahoo Finance ·
- Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Yahoo Finance ·
- Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes
Yahoo Finance ·
- Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
Yahoo Finance ·
Fortress Biotech, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $63.3M | $57.7M | $84.5M | $75.7M |
| Net income | $37.0M | $21.0M | $31.0M | -$86.6M |
| Diluted EPS | $-0.07 | $-2.69 | $-8.47 | $-15.97 |
| Total assets (year end) | $185.5M | $144.2M | $167.5M | $294.3M |
| Cash and equivalents (year end) | $79.4M | $57.3M | $80.9M | $178.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Fortress Biotech, Inc.
- Ticker
- FBIOP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bay Harbor Islands, FL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1429260
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Frequently asked questions
What exchange is Fortress Biotech, Inc. listed on?
Fortress Biotech, Inc. trades on the Nasdaq under the ticker symbol FBIOP.
What industry is Fortress Biotech, Inc. in?
Fortress Biotech, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Fortress Biotech, Inc. headquartered?
Fortress Biotech, Inc.'s business address on file with the SEC is in Bay Harbor Islands, FL.
When does Fortress Biotech, Inc.'s fiscal year end?
Fortress Biotech, Inc.'s fiscal year ends on December 31.
How much revenue did Fortress Biotech, Inc. report?
Fortress Biotech, Inc. reported $63.3M in revenue for calendar year 2025, according to its SEC filings.